Generics 29

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Drospirenone manufacturers

29 products found

Filters

29 products found

drospirenone + ethinylestradiol

Tablets, film coated 3 mg + 0.02 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Flexyess®, Yasminelle®, Yaz®
Manufacturer #252

Manufacturer usually replies in 2 days

drospirenone + ethinylestradiol

Tablets 3 mg + 0.020 mg, 3 mg + 0.030 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Manufacturer #8686
A pharmaceutical company that focuses on manufacturing and development of pharmaceuticals. The company is compliant with GMP and quality control, and has other certificates, for example, ANVISA. This manufacturer is based in Europe but is active in 40+ countries worldwide. Main focus: steroid drugs for therapies, reproductive health, oncology, and more.

Manufacturer usually replies in 11 days

drospirenone + ethinylestradiol

Tablets, film coated 3 mg / 0.03 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #354

drospirenone + ethinylestradiol

Tablets, film coated 3 mg + 30 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
EU MA’s Running
Manufacturer #21467

Manufacturer usually replies in 4 days

drospirenone + ethinylestradiol

Tablets, film coated 3 mg + 20 mcg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21467

Manufacturer usually replies in 4 days

drospirenone

Tablets, film coated 4 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21467

Manufacturer usually replies in 4 days

drospirenone + ethinylestradiol

Tablets 3 mg + 0.03 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #17708

Manufacturer usually replies in 4 days

drospirenone + ethinylestradiol

Tablets 3 mg + 0.03 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #634
A pharmaceutical manufacturer based in Asia that is active in 20+ countries for 10+ years. The company develops and manufactures API and FDF. The main therapeutic area is women's health.

Manufacturer usually replies in 6 days

drospirenone + ethinylestradiol

Tablets 3 mg + 30 mg, 3 mg + 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
EU GMP, COFEPRIS, INVIMA
Manufacturer #18696
The company has an experience of more than 80 years of medicine. It is one of the leading companies in a wide range of quality pharmaceuticals for both the prescription medication and the OTC market. They are committed to excellence, high quality, and social standards and pledge to offer quality products at accessible prices, which constitute the basis of our success.

Manufacturer usually replies in 7 days

drospirenone + ethinylestradiol

Tablets Upon request

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

drospirenone + estradiol

Tablets 3 mg + 0.02 mg, 3 mg + 0.03 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 4 days

drospirenone

Tablets 4 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

drospirenone + ethinylestradiol

Tablets 3 mg + 0.02 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

drospirenone + ethinylestradiol

Tablets for oral solution 3 mg + 0.03 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19861

Manufacturer usually replies in 3 days

drospirenone + ethinylestradiol

Tablets, film coated 3mg+0,03mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18979
The company has stood out in the national pharmaceutical market and is currently among the top 20 laboratories in the ranking, according to the IMS. The mission expresses the commitment to working towards health and meeting the needs of the population, ethically, seeking to gain more and more the trust of doctors and consumers. Its distribution network of medicines MIP (medicines without prescription) is present throughout the national territory and the activity of propagation of medicines with the medical class expands gradually, reaching today 24 states of the federation.

Manufacturer usually replies in 3 days

drospirenone + ethinylestradiol

Tablets 3 mg + 0.03 mg, 3 mg + 0.02 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18978
The company is focused to bring quality to the needs of people's lives. The company is focused on innovation, lifestyle, and freedom. The company continues the maintenance of its leadership position with new products and entry into new markets.

Manufacturer usually replies in 4 days

drospirenone + levomefolate calcium

Tablets 0.02 mg + 0.075 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

drospirenone + ethinylestradiol

Tablets 3 mg + 0.03 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17816

Manufacturer usually replies in 4 days

drospirenone + ethinylestradiol

Tablets 3 mg + 0.03 mg, 3 mg + 0.02 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
FDA
Manufacturer #20781
The vision of the company is to develop and promote local expertise in the pharmaceutical industry. With the mission of quality medicines, health, and well-being of people and the environment. They manufacture and market high-quality branded generics in more than 40 countries across the globe.

Manufacturer usually replies in 9 days

drospirenone + ethinylestradiol

Tablets 3 mg + 0.03 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

Want to view all 29 products? Create your free account today!

Drospirenone:

Drospirenone, also known under the brand name Slynd, or in combination with oestrogen where it is commonly sold under the name Yasmin, is a progestin medication which is used in birth control pills. These pharmaceutical products are prescribed to prevent pregnancy and are also used in menopausal hormone therapy, along with the treatment of a few other indications.
Drospirenone is known as a fourth-generation progestin, with the original patent being granted to the drugs manufacturing company Schering AG in 1976 and subsequently emerged onto the medical marketplace in 2000. With drospirenone manufacturers and drospirenone suppliers being granted additional patents including WIPO and US in 1998 and 2000, respectively. More recently, the medication was approved for use in menopausal hormone therapy in combination with estradiol in 2005 and was introduced for use as a progestogen-only birth control pill in 2019.
Currently, due to the expiration of patents and its wide regulatory approval, drospirenone has become cost-effective for distributors to list for sale and wholesale on the global marketplace. As such, drospirenone, especially in combination with ethinylestradiol, has become widely available for order at a variety of price points and quantities.

Method of action of drospirenone:

Drospirenone functions through its antiandrogen effects, improving acne and hirsutism, while also inhibiting the maturation of follicles and ovulation, preventing pregnancy. It is an analogue of the diuretic spironolactone, which involves anti-mineralocorticoid activity, inhibiting aldosterone receptors, which increases sodium and water excretion. In essence, drospirenone suppresses the release of both the follicle-stimulating hormone and luteinizing hormone, preventing ovulation, while also inducing other changes which may aid in pregnancy prevention. Such as alterations in cervical mucus consistency, hindering sperm movement, and lowering the chance of embryo implantation.

Form and dosage of drospirenone:

As with other drugs, the final form and packaging are dependent on the manufacturers and suppliers, as well as the specific distributor and order. However, drospirenone is predominantly listed for sale as a combination medication along with ethinylestradiol. It comes in forms including tablets and film-coated tablets which are taken orally, with or without food. Typically for use in pregnancy prevention and menstruation regulation, it is recommended that the medication be taken once daily during the 21-day cycle, followed by 7 days abstinence. For the use in the treatment of other indications, drospirenone regimes tend to be bespoke to the needs of the specific patient, as such, the prescribing medical official’s and manufacturers’ instructions should be adhered to.

Drospirenone on Pipelinepharma:

Currently, we have found 13 trusted drospirenone manufacturers and drospirenone suppliers from our online global list of B2B sellers. These distributors have drospirenone available for order online and are located in countries including India, Brazil, the European Union, and Argentina. Each of the manufacturing and B2B wholesale companies on our online pharmaceutical products list has been verified by the Pipelinepharma team according to strict quality control. This ensures a hassle-free sourcing experience and reduces buyer mileage.

Price of drospirenone and how to buy:

Although the cost of drospirenone is highly dependent on numerous factors, a cursory search online reveals a typical B2B wholesale cost at approximately USD 18.92 for 63 tablets of drospirenone at 3 mg and ethinylestradiol at 30 micrograms. These values are for the NHS in the UK, as such are only intended for reference. Finding drospirenone manufacturers and drospirenone suppliers on the Pipelinepharma company marketplace is easy, simply search for the desired pharmaceutical products, select the listing of choice, and then press either the ‘Accept’, ‘Negotiate’, or ‘Get offer’ button on the online interface to begin a transaction.